ArticleOncology reports2019

Cystatin F as a key family 2 cystatin subunit and prognostic biomarker for early‑stage pancreatic ductal adenocarcinoma.

Chengkun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.